Why is this important?
Controlled substance legislation has changed rapidly in recent years as legislators respond to the issues and concerns in society. For example, enhanced suspicious order monitoring requirements in response to the opioid epidemic and ‘super generic’ definitions in response to the rapid increase in synthetic cannabinoid analogs in the mid-2010s. Remaining compliant in this environment is an ever-growing challenge and consequences for breaches are severe.
High levels of compliance are vital to the credibility of and public trust in life science R&D. Enhancing the knowledge of practitioners supports the goal of our industry – improving the health outcomes of all.
This community brings together experts to discuss and work on current controlled substance issues. In the past, the group has facilitated the creation of systems that are used today by governments and top pharma companies to look up the controlled status of a chemical structure across multiple countries and for alerts on new legislation.
The CSCS Expert Community provides a forum to discuss new developments and share best practices. Members hear from expert external speakers, respond to public consultations, and build links with regulators.
